Tiffany, Kors to Re...
Health Care: Drugs
Biogen Idec Inc (BIIB: NASDAQ)
$235.24 2.62 | 1.13%
05/24/13 - 04:00 PM ET
TheStreet Ratings Grade for BIIB
| Buy | Hold | Sell | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| A+ | A | A- | B+ | B | B- | C+ | C | C- | D+ | D | D- | E+ | E | E- | F |
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions.
Analyst Ratings
| Historical Rec | Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago |
|---|---|---|---|---|
| Strong Buy | 11 | 9 | 9 | 9 |
| Moderate Buy | 1 | 1 | 1 | 1 |
| Hold | 9 | 11 | 11 | 11 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Mean Rec. | 1.90 | 2.10 | 2.10 | 2.10 |
Portfolios with BIIB
- Portfolio NameUser Type
- User4 Overvalued Biotechs
- UserCorgies Follies
- ProNavellier & Associates
- UserMy SP portfolio
- ContributorDrugs Facing FDA Approval i...
- Contributor22 Biopharma Stocks With Br...
- UserKAREL VON ZOETE
- UserEverett Bishop Portfolio 1
- ProViking Global Investors
- ContributorTop-Rated Biotechnology Stocks
Latest BIIB Headlines from TheStreet
- Biogen Idec Inc (BIIB): Today's Featured Drugs Winner 05.24.13 | 05:05 pm
- Cramer's 'Mad Money' Recap: Ignore the Fed 05.22.13 | 07:05 pm
- Biogen Idec Stock Hits New 52-Week High (BIIB) 05.22.13 | 10:05 am
- AGN, LLY, BIIB, CELG And AMGN, Pushing Health Care Sector Downward 05.16.13 | 01:05 pm
- Biogen Idec Inc (BIIB): Today's Featured Health Care Laggard 05.15.13 | 05:05 pm
- Cramer's 'Mad Money' Recap: Stick With What Works 05.14.13 | 08:05 pm
- Biogen Idec Stock Hits New 52-Week High (BIIB) 05.14.13 | 10:05 am
- Cramer: Biotech Makes a Comeback 05.10.13 | 04:05 pm
- 'Mad Money' Lightning Round: Buy, Buy, Buy Biogen 05.10.13 | 06:05 am
- Cramer's 'Mad Money' Recap: Looking for Real Leaders 05.09.13 | 08:05 pm
Press Releases for BIIB
- Image Of Biogen Idec's TECFIDERA(TM) (dimethyl Fumarate) Which Was Approved By The U.S. FDA On March 27, 2013 For Relapsing Multiple Sclerosis. (Photo: Business Wire) - Business Wire 03.27.13 | 04:03 pm
- CHMP Issues Positive Opinion For TECFIDERA™ (Dimethyl Fumarate) As A First-Line Treatment For Multiple Sclerosis In The European Union - Business Wire 03.22.13 | 08:03 am
- Positive Year One Results From Biogen Idec Phase 3 ADVANCE Trial Of PLEGRIDY™ (Peginterferon Beta-1a) Presented At AAN Meeting - Business Wire 03.20.13 | 07:03 am
- US Patent Office Grants Patent Claiming Dosing Regimen For TECFIDERA™ (Dimethyl Fumarate) - Business Wire 03.19.13 | 04:03 pm
- New TYSABRI Data Reaffirm Substantial Efficacy In Treatment Of People With MS And Demonstrate Stability Of Anti-JCV Antibody Status - Business Wire 03.18.13 | 07:03 am
- Biogen Idec To Present New Data On Diverse Neurological Portfolio At 65th AAN Annual Meeting - Business Wire 03.06.13 | 01:03 pm
- FDA Accepts Biogen Idec’s Biologics License Application For First Long-Lasting Factor IX Therapy For Hemophilia B - Business Wire 03.04.13 | 07:03 am
- Biogen Idec To Present At The Cowen And Company 33rd Annual Healthcare Conference - Business Wire 02.27.13 | 04:02 pm
- Biogen Idec To Present At The 2013 RBC Capital Markets Global Healthcare Conference - Business Wire 02.20.13 | 04:02 pm
- Biogen Idec To Present At The Citi 2013 Global Healthcare Conference - Business Wire 02.19.13 | 04:02 pm
Partner Headlines for BIIB
- Indexes Notch Sharp Declines; New 52-Week Low For Apple - Investor's Business Daily 04.17.13 | 04:04 pm
- Biotech Alkermes Poised To Swell On Pipeline Wins - Investor's Business Daily 04.16.13 | 05:04 pm
- Big Cap Leaders Slide But Show Little Technical Damage - Investor's Business Daily 04.15.13 | 07:04 pm
- Pockets of Strength In Top Groups, Few Leaders Basing - Investor's Business Daily 04.15.13 | 06:04 pm
- Sellers Smack Indexes Lower; Gold, Growth Names Slump - Investor's Business Daily 04.15.13 | 05:04 pm
- Acorda: A Biotech Company To Consider - Seeking Alpha 04.13.13 | 09:04 am
- Stocks End With Mild Losses; Nasdaq Rises 2.8% For Week - Investor's Business Daily 04.12.13 | 05:04 pm
- Stocks Lift Off Session Lows; Proto Labs Tumbles - Investor's Business Daily 04.12.13 | 01:04 pm
- Stocks Slip In Mixed Trade; Sinclair Broadcast Hits New High - Investor's Business Daily 04.12.13 | 11:04 am
- Benzinga's Top Pre-Market Gainers - Benzinga 04.12.13 | 09:04 am
